Whitetramaju (Tramadol Hydrochloride)
Tramadol Hydrochloride 50mg
Prescription medication
Whitescience Co., Ltd.
MFDS item code 201606622 · Notified 2016.11.15 · Insurance code 625201731
Relief of moderate to severe acute or chronic pain (such as cancer pain) and pain after diagnostic procedures or surgery
This medication is used for severe and moderate acute and chronic pain, for example, various types of cancer pain and pain occurring after diagnosis or surgery.
The dose of this medicine should be adjusted according to the patient's pain intensity and clinical response. In general, the lowest dose that relieves pain should be administered. Adults After administering 50-100mg of tramadol hydrochloride intravenously or intramuscularly as a single dose, repeat the injection every 4-5 hours as needed. A maximum of 400mg per day may be administered. Elderly patients No dose adjustment is necessary in patients aged 75 years or younger who have no clinically confirmed hepatic or renal impairment. In patients older than 75 years, elimination of this medicine may be delayed; therefore, adjust the dosing interval as needed. Patients with renal impairment/on dialysis or patients with hepatic impairment Elimination of this medicine may be delayed in patients with renal or hepatic impairment; therefore, consider extending the dosing interval in these patients.
This medication can cause seizures if taken in excess of the recommended dosage, so the prescribed dosage must be strictly followed. Additionally, this medication may increase the risk of seizures, so it should only be used when absolutely necessary in patients with a history of epilepsy or seizure risk. Long-term use can lead to psychological and physical dependence, so patients at risk of drug abuse should be managed and administered strictly over a short term. Using this medication with alcohol or central nervous system depressants (such as benzodiazepines) can lead to severe sedation, respiratory depression, coma, and the risk of death, so this combination should be avoided or used in the minimum effective dose for the shortest time necessary with close monitoring of the patient. Individuals who metabolize this drug rapidly due to genetic factors may have higher levels of the active metabolite in the blood, increasing the risk of respiratory depression, thus requiring dose adjustments and symptom monitoring. This drug should not be used in children under 12 or adolescents under 18 who have undergone tonsillectomy or adenoidectomy. In adolescents aged 12 to 18 with risk factors for respiratory depression, administration is also discouraged. This medication should not be administered to patients with acute alcohol intoxication, central nervous system drug poisoning, severe respiratory depression, head injuries, patients taking or having taken MAO inhibitors within the past 14 days, patients with severe kidney and liver dysfunction, pregnant and breastfeeding women, and those with certain genetic disorders. Patients taking morphine or with a history of epilepsy or seizures, drinkers, and those who are sensitive to opioids should use this medication cautiously, as there is an increased risk of dependence in individuals with a history of drug abuse or mental illness. This medication may cause side effects such as drowsiness, dizziness, nausea, and vomiting, thus driving or operating dangerous machinery should be avoided after taking it. Long-term use may result in tolerance requiring increased dosages, and sudden discontinuation may provoke withdrawal symptoms; hence, the dosage should be gradually reduced. In the event of an overdose, severe respiratory depression and seizures may occur, requiring immediate emergency care, and naloxone may be used as an antidote if necessary. This medication may interact with various drugs, so anyone currently taking other medications must consult a doctor or pharmacist. It is safest for pregnant or breastfeeding women to avoid using this medication. In breastfeeding, caution is necessary as the drug may pass into breast milk and cause severe side effects in the infant. Elderly patients (those over 75 years) may have increased blood levels, so it is advisable to limit the dosage to 300mg per day.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid contact with air and is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage maintains the drug’s effectiveness and prevents degradation.
Colorless and transparent ampoules containing a colorless liquid
1ml/ampoule x 50 ampoules / BOX
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tramadol Hydrochloride 50mg
Prescription medication
Whitescience Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
(Yuhan Corporation)

Tramadol Hydrochloride 50mg
Hard capsule · Prescription medication
Yuhan Corporation
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Hanol BioPharma Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
Il Sung IS Co., Ltd.
Tramadol Hydrochloride 100mg
Prescription medication
Il Sung IS Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
Ilseong IS Co., Ltd.
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Donggwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.